GSA Capital Partners LLP Purchases New Stake in CVS Health Co. (NYSE:CVS)

GSA Capital Partners LLP bought a new position in shares of CVS Health Co. (NYSE:CVS - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 12,985 shares of the pharmacy operator's stock, valued at approximately $816,000.

A number of other hedge funds also recently bought and sold shares of the company. Apollon Wealth Management LLC grew its holdings in CVS Health by 5.0% in the 3rd quarter. Apollon Wealth Management LLC now owns 33,635 shares of the pharmacy operator's stock valued at $2,115,000 after buying an additional 1,608 shares during the last quarter. Versor Investments LP bought a new stake in shares of CVS Health in the third quarter valued at approximately $371,000. Delta Financial Advisors LLC grew its stake in shares of CVS Health by 13.2% in the third quarter. Delta Financial Advisors LLC now owns 35,096 shares of the pharmacy operator's stock worth $2,207,000 after acquiring an additional 4,080 shares during the last quarter. Addison Advisors LLC increased its position in CVS Health by 187.8% during the third quarter. Addison Advisors LLC now owns 7,815 shares of the pharmacy operator's stock worth $491,000 after acquiring an additional 5,100 shares during the period. Finally, Proffitt & Goodson Inc. raised its stake in CVS Health by 9.5% during the 3rd quarter. Proffitt & Goodson Inc. now owns 10,237 shares of the pharmacy operator's stock valued at $644,000 after purchasing an additional 891 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Price Performance

Shares of NYSE:CVS traded down $1.90 during trading on Friday, reaching $53.19. The stock had a trading volume of 16,695,415 shares, compared to its average volume of 13,766,502. The stock has a market capitalization of $66.93 billion, a PE ratio of 13.50, a P/E/G ratio of 0.92 and a beta of 0.55. CVS Health Co. has a 52 week low of $52.71 and a 52 week high of $83.25. The business's 50-day moving average price is $59.23 and its 200 day moving average price is $58.60. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same quarter in the previous year, the firm earned $2.21 earnings per share. The business's revenue was up 6.3% on a year-over-year basis. As a group, equities analysts predict that CVS Health Co. will post 5.48 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.00%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health's dividend payout ratio is presently 67.51%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on CVS. Truist Financial boosted their price objective on shares of CVS Health from $66.00 to $76.00 and gave the stock a "buy" rating in a report on Friday, October 11th. Mizuho lowered their price target on CVS Health from $73.00 to $66.00 and set an "outperform" rating on the stock in a research note on Thursday, October 24th. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. TD Cowen raised CVS Health from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Finally, Wells Fargo & Company cut their target price on CVS Health from $61.00 to $60.00 and set an "equal weight" rating for the company in a research note on Monday, November 4th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $72.44.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.